This bill authorizes pharmacists in New Jersey to dispense HIV preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) without an individual prescription under specific conditions, including the completion of an approved training program and adherence to established protocols. Pharmacists must confirm that patients have a recent negative HIV test, are not exhibiting acute HIV symptoms, and provide counseling on ongoing use and follow-up care. The bill also requires pharmacists to document the services provided and notify the patient's primary care provider, unless the patient opts out. Additionally, it allows pharmacists to provide a complete course of PEP to patients who may have been exposed to HIV within the last 72 hours, contingent on meeting clinical criteria and undergoing HIV testing.

Furthermore, the bill mandates that health insurance contracts cover PrEP and PEP without requiring prior authorization or step therapy, ensuring patients can access these medications without unnecessary barriers. It specifies that coverage must be provided for at least one version of the medication without prior authorization, even if there are therapeutically equivalent alternatives. The legislation aims to enhance access to HIV prevention and treatment services while empowering pharmacists to play a vital role in public health efforts against HIV.